Cytokine profile in relapsing-remitting multiple sclerosis patients and the association with the progression and the activity of the disease

被引:0
|
作者
Kallaur, Ana Paula
Oliveira, Sayonara Rangel
Colado Simao, Andrea Name
Delicato de Almeida, Elaine Regina
Morimoto, Helena Kaminami
Kaimen-Maciel, Damacio Ramon
Lopes, Josiane
de Carvalho Jennings Pereira, Wildea Lice
Andrade, Renato Marques
Pelegrino, Larissa Muliterno
Vissoci Reiche, Edna Maria
机构
关键词
cytokines; multiple sclerosis; disease activity; disability; disease progression;
D O I
暂无
中图分类号
R74 [神经病学与精神病学];
学科分类号
摘要
引用
收藏
页码:1832 / 1832
页数:1
相关论文
共 50 条
  • [1] Cytokine profile in relapsing-remitting multiple sclerosis patients and the association between progression and activity of the disease
    Kallaur, Ana Paula
    Oliveira, Sayonara Rangel
    Colado Simao, Andrea Name
    Delicato De Almeida, Elaine Regina
    Morimoto, Helena Kaminami
    Lopes, Josiane
    De Carvalho Jennings Pereira, Wildea Lice
    Andrade, Renato Marques
    Pelegrino, Larissa Muliterno
    Borelli, Sueli Donizete
    Kaimen-Maciel, Damacio Ramon
    Vissoci Reiche, Edna Maria
    MOLECULAR MEDICINE REPORTS, 2013, 7 (03) : 1010 - 1020
  • [2] 25 Hydroxyvitamin D and Cytokine Profile in Patients With Relapsing-Remitting Multiple Sclerosis
    Slavov, Georgi S.
    Manova, Mariya G.
    Kostadinova, Ivanka I.
    CUREUS JOURNAL OF MEDICAL SCIENCE, 2024, 16 (06)
  • [3] Long-term disease activity and disability progression in relapsing-remitting multiple sclerosis patients on natalizumab
    Dekker, I
    Leurs, C. E.
    Hagens, M. H. J.
    van Kempen, Z. L. E.
    Kleerekooper, I
    Lissenberg-Witte, B., I
    Barkhof, F.
    Uitdehaag, B. M. J.
    Balk, L. J.
    Wattjes, M. P.
    Killestein, J.
    MULTIPLE SCLEROSIS AND RELATED DISORDERS, 2019, 33 : 82 - 87
  • [4] Premorbid physical activity predicts disability progression in relapsing-remitting multiple sclerosis
    Motl, Robert W.
    Dlugonski, Deirdre
    Pilutti, Lara
    Sandroff, Brian
    McAuley, Edward
    JOURNAL OF THE NEUROLOGICAL SCIENCES, 2012, 323 (1-2) : 123 - 127
  • [5] Osteopontin levels and increased disease activity in relapsing-remitting multiple sclerosis patients
    Vogt, MHJ
    Floris, S
    Killestein, J
    Knol, DL
    Smits, M
    Barkhof, F
    Polman, CH
    Nagelkerken, L
    JOURNAL OF NEUROIMMUNOLOGY, 2004, 155 (1-2) : 155 - 160
  • [6] Cerebrovascular reactivity and disease activity in relapsing-remitting multiple sclerosis
    Smolinski, Lukasz
    Litwin, Tomasz
    Kruk, Karolina
    Skowronska, Marta
    Kurkowska-Jastrzebska, Iwona
    Czlonkowska, Anna
    ADVANCES IN CLINICAL AND EXPERIMENTAL MEDICINE, 2020, 29 (02): : 183 - 188
  • [7] Predictors of Disease Activity and Worsening in Relapsing-Remitting Multiple Sclerosis
    Zhang, Yinan
    Cofield, Stacey
    Cutter, Gary
    Krieger, Stephen
    Wolinsky, Jerry S.
    Lublin, Fred
    NEUROLOGY-CLINICAL PRACTICE, 2022, 12 (04) : E58 - E65
  • [8] Flexible modeling of disease activity measures improved prognosis of disability progression in relapsing-remitting multiple sclerosis
    Le Teuff, Gwenael
    Abrahamowicz, Michal
    Wynant, Willy
    Binquet, Christine
    Moreau, Thibault
    Quantin, Catherine
    JOURNAL OF CLINICAL EPIDEMIOLOGY, 2015, 68 (03) : 307 - 316
  • [9] Daclizumab for the treatment of relapsing-remitting multiple sclerosis
    Herwerth, Marina
    Hemmer, Bernhard
    EXPERT OPINION ON BIOLOGICAL THERAPY, 2017, 17 (06) : 747 - 753
  • [10] Imbalance in T-cell and cytokine profiles in patients with relapsing-remitting multiple sclerosis
    Mikulkova, Z.
    Praksova, P.
    Stourac, P.
    Bednarik, J.
    Michalek, J.
    JOURNAL OF THE NEUROLOGICAL SCIENCES, 2011, 300 (1-2) : 135 - 141